These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32863846)

  • 1. Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial.
    Jafari-Maskouni S; Shahraki M; Daneshi-Maskooni M; Dashipour A; Shamsi-Goushki A; Mortazavi Z
    Nutr Metab (Lond); 2020; 17():74. PubMed ID: 32863846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
    Aghasi M; Koohdani F; Qorbani M; Nasli-Esfahani E; Ghazi-Zahedi S; Khoshamal H; Keshavarz A; Sotoudeh G
    J Sci Food Agric; 2019 Jun; 99(8):3933-3940. PubMed ID: 30701554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theobromine supplementation in combination with a low-calorie diet improves cardiovascular risk factors in overweight and obese subjects with metabolic syndrome: a randomized controlled trial.
    Sharifi-Zahabi E; Rezvani N; Hajizadeh-Sharafabad F; Hosseini-Baharanchi FS; Shidfar F; Rahimi M
    Food Funct; 2023 Sep; 14(18):8431-8441. PubMed ID: 37615657
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of green coffee aqueous extract supplementation on glycemic indices, lipid profile, CRP, and malondialdehyde in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Khalili-Moghadam S; Hedayati M; Golzarand M; Mirmiran P
    Front Nutr; 2023; 10():1241844. PubMed ID: 38035358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Karamzad N; Faraji E; Adeli S; Carson-Chahhoud K; Azizi S; Pourghassem Gargari B
    Diabetes Metab Syndr Obes; 2020; 13():2239-2249. PubMed ID: 32617013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study.
    Khosravi ZS; Kafeshani M; Tavasoli P; Zadeh AH; Entezari MH
    Int J Prev Med; 2018; 9():63. PubMed ID: 30123437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial.
    Hadi A; Sepandi M; Marx W; Moradi S; Parastouei K
    Complement Ther Med; 2019 Dec; 47():102216. PubMed ID: 31780038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial.
    Fallah F; Mahdavi R
    Front Endocrinol (Lausanne); 2023; 14():1237882. PubMed ID: 37929031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of concentrated beetroot juice consumption on glycemic control, blood pressure, and lipid profile in type 2 diabetes patients: randomized clinical trial study.
    Karimzadeh L; Sohrab G; Hedayati M; Ebrahimof S; Emami G; Razavion T
    Ir J Med Sci; 2023 Jun; 192(3):1143-1153. PubMed ID: 35869311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cardamom supplementation on serum lipids, glycemic indices and blood pressure in overweight and obese pre-diabetic women: a randomized controlled trial.
    Fatemeh Y; Siassi F; Rahimi A; Koohdani F; Doostan F; Qorbani M; Sotoudeh G
    J Diabetes Metab Disord; 2017; 16():40. PubMed ID: 29026804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synbiotic Supplementation Improves Metabolic Factors and Obesity Values in Women with Polycystic Ovary Syndrome Independent of Affecting Apelin Levels: A Randomized Double-Blind Placebo - Controlled Clinical Trial.
    Darvishi S; Rafraf M; Asghari-Jafarabadi M; Farzadi L
    Int J Fertil Steril; 2021 Jan; 15(1):51-59. PubMed ID: 33497048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of retinol binding protein 4 with 
metabolic indexes of glucose and 
lipid, bile cholesterol saturation index].
    Wang W; Li N
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):657-65. PubMed ID: 26164516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial.
    Cabrera-Rode E; Cubas-Dueñas I; Acosta JR; Hernández JC; González AIC; Calero TMG; Domínguez YA; Rodríguez JH; Rodríguez ADR; Álvarez Álvarez A; Valdés RE; Espinosa LJ; Belent OT; Benavides ZB; Estévez ES; Rodríguez YA; Del Valle Rodríguez J; Juliá SM
    BMC Complement Med Ther; 2023 Feb; 23(1):58. PubMed ID: 36804035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Zinc Sulfate Supplementation on Serum Copeptin, C-Reactive Protein and Metabolic Markers in Zinc-Deficient Diabetic Patients on Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hosseini R; Montazerifar F; Shahraki E; Karajibani M; Mokhtari AM; Dashipour AR; Ferns GA; Jalali M
    Biol Trace Elem Res; 2022 Jan; 200(1):76-83. PubMed ID: 33655432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.